Arpida Ltd.

Arpida Ltd., based in Münchenstein/Basel, Switzerland, is dedicated exclusively to the research and development of novel antibiotics for the treatment of infectious diseases.

Efforts are focused on new therapies that address the problems of anti-microbial resistance or the needs of patients who have no or few available therapies.

In October 2004, Arpida Ltd. acquired the Danish drug discovery company Combio A/S.
Arpida is listed on SWX: ARPN.

Visit Arpida